To investigate transmission of human herpesvirus (HHV)-
tected in the saliva of infected individuals, at varying frequencies and at different levels, and has been proposed as an infectious source of virus [12, 13] . Transmission via breast milk is also a theoretical possibility (another herpesvirus, cytomegalovirus, is transmissible via breast milk). To investigate this possibility further, we conducted a case-control study of mother-child pairs in rural South Africa, focusing on potential routes of mother-to-child transmission of HHV-8. The study was conducted in an area where both HIV and HHV-8 are prevalent [14, 15] .
SUBJECTS AND METHODS
Hlabisa district is situated in KwaZulu/Natal, South Africa, ∼250 km north of Durban. It covers an area of 3729 km 2 and has a population of ∼220,000 people, predominantly Zulu [16] . The district has a single government hospital and 15 rural health clinics (staffed by nurses) that are used by almost the entire population; only a minority can afford private health insurance. Between August 2000 and December 2002, we systematically recruited mothers attending any of 6 staterun vaccination clinics with their children. The clinics used were all based in the most rural parts of the district and were at least 15 km from a paved road.
Ethical approval for the present study was granted by the University of Natal and the Liverpool School of Tropical Medicine ethical review boards. Signed, informed consent was obtained from all participants in the study. All participants had the study explained to them in isiZulu, by trained Zulu field workers. The information given and consent form signed were in accordance with the guidelines issued by the University of Natal for research projects that include isiZulu-speaking participants. After informed consent and counseling, mothers were interviewed briefly and asked about social, demographic, and health-related factors. Questionnaires were administered by 1 of 6 trained interviewers in the native language of the mother. Children brought for vaccination by someone other than the biological mother were not included in the study. After the interview, spots of blood were collected from both the mother and child via a finger or heel prick onto filter paper (grade 903; Schleicher and Schuell). Saliva samples were collected from both mothers and children (for infants, saliva was collected by use of a pipette). If possible, breast-milk samples were collected from lactating mothers. All samples were stored at Ϫ20ЊC. On a weekly basis, samples were taken to Durban for storage and for HIV testing on 1 of the blood spots. The mother's HIV status was determined by antibody testing by use of a broadbased HIV-1/HIV-2 ELISA (Vironostika; Organon Teknika) and was confirmed by use of another ELISA (Murex Wellcozyme HIV 1+2 GAC-ELISA). Infants were tested for HIV-1 RNA by use of the NucliSens QT assay (Organon Teknika). This assay has a sensitivity of 1600 HIV-1 RNA copies/50 mL of dried plasma. These techniques have been shown to be accurate and reliable for use with subtype C HIV, which is found in South Africa [17] . If the mother wanted to know her HIV status or that of her child, the results were given at a subsequent clinic visit by trained HIV counselors.
Remaining samples of blood, saliva, and breast milk were shipped on dry ice to the Department of Virology at Hannover Medical School (Hannover, Germany). Assays for HHV-8 were conducted by a single investigator in a blinded fashion. An EIA for K8.1 glycoprotein, a lytic-phase antigen, was used to detect HHV-8 lytic antibodies. In European and African populations, this assay has been shown to be both sensitive and specific [18, 19] . The K8.1 EIA has been described in detail elsewhere [18] . In brief, blood spots were eluted in PBS overnight. Then the samples were diluted 1:3 and added to ELISA plates that had been precoated with K8.1 protein. After incubation, a conjugate antihuman antibody was added, and, after a further period of incubation, substrate solution containing nitrophenyl phosphate (Sigma) was added, and the plates were immediately read spectrophotometrically at 405 nm by use of a standard EIA plate reader (Diagnostics Power CP400). To determine positive samples, first, a mean optical density for the 10 negative controls was determined. Samples were scored as negative if their optical density was !5 SD from the mean of the negative samples. Samples with higher optical density were scored as positive. Those whose optical density was 5-7 SD above the mean were scored as "1+," those whose optical density was 8-10 SD above the mean were scored as "2+," and those whose optical density was 110 SD above the mean were scored as "3+." Each set of plates contained 2 positive controls. If these were not scored in the 3+ category, the plate was repeated. Sensitivity and specificity of both the K8.1 EIA and latency-associated nuclear antigen (LANA) assay performed on blood spots, compared with serum samples, was calculated by analyzing 71 matched blood-spot and serum sample pairs from 44 South African hospital patients and 27 HIV-infected men from the United Kingdom. In the present study, the specificity of K8.1 EIA on blood spots, compared with serum samples, was 70%, and the sensitivity was 81%.
Antibodies against HHV-8 LANA were detected by use of an indirect immunofluorescence assay (IFA), as described elsewhere [21] . The assay has been shown to be reliable in testing samples from Africa [20, 21] . In brief, blood spots were eluted overnight in PBS, and slides were coated with permeabalized BCP-1 lymphoma cells, which are latently infected with HHV-8. Eluted serum samples were tested at a dilution of 1:10. The slides were read immediately, by use of a fluorescent microscope, by 2 independent observers. A sample was scored as positive if it showed clear, punctate nuclear staining. Positive samples were further diluted and retested at concentrations of 1:20 and 1:40. Compared with serum samples, in the present study, blood-spot IFA had a specificity of 90% and a sensitivity of 80%.
HHV-8 DNA was detected in saliva by use of a real-time quantitative polymerase chain reaction (PCR) directed against a 171-bp region of the viral open-reading frame K6. The TaqMan probe with a reporter dye at its 5 end and a quencher dye at its 3 end had the sequence 5 -(6-FAM) CACCCACCGCCCGTCCA-AATC (TAMRA-FAM)-3 . Amplification primers were K6-10 (forward, 5 -CGCCTAATAGCTGCTGCTACGG-3 ) and K6-10 (reverse, 5 -TGCATCAGCTGCCTAACCCAG-3 ) and were used at final concentrations of 0.4 mmol/L. The hot-start reaction mix and the LightCycler (Roche) were used to monitor the increase in florescence. DNA was extracted from 200 mL of saliva by use of the Qiagen DNA extraction kit, following the manufacturer's instructions, and eluted in 50 mL of water. The quantitative PCR can reliably detect and quantify 30 copies of DNA/PCR and, with the extraction procedure used, this equates to a quantification limit of 1500 genome copies/mL of saliva. HHV-8 DNA was extracted from breast milk as described for saliva, after first removing the lipid fraction by repeat centrifugation.
Data were computerized by trained clerks using Epi Info software (Centers for Disease Control and Prevention), and statistical analyses were conducted by use of STATA software (version 7; STATA). Odds ratios (ORs) were estimated by use of unconditional logistic regression modeling, with adjustment for maternal age; tests for association used the x 2 test on 1 df. P values are 2 sided. Where indicated in the text and tables, analyses were restricted to mother-child pairs in which the child was aged 11 year, to exclude the possibility of detecting passively acquired maternal antibodies against HHV-8 antigens. Similarly, where indicated, analyses were restricted to HIV-seronegative mothers and their children, because the effect of HIV infection on the ability to detect anti-HHV-8 antibodies is unclear.
RESULTS
In total, 2546 mother-child pairs were recruited. Figure 1 shows the recruitment process and the prevalence of antibodies against HHV-8 lytic and latent antigens and against HIV. The seroprevalence of HIV was 28% (705/2520) among mothers and 22% (155/705) among children of HIV-infected mothers. Among mothers, the prevalence of antibodies was 40% (1009/2512) against HHV-8 lytic antigens and 14% (349/2490) against latent antigens; 8% (205) of mothers were seropositive in both HHV-8 assays, 6% (175) had latent antibodies only, 32% (796) had lytic antibodies only, 46% (1176) had antibodies against at least 1 viral antigen, and 54% (1339) were seronegative in both assays. Among children, the prevalence of antibodies was 12% (288/2501) against lytic antigens and 7% (176/2486) against latent antigens; 1% (29) of children were seropositive in both HHV-8 assays, 6% (146) had latent antibodies only, 11% (259) had lytic antibodies only, 18% (434) had antibodies against at least 1 viral antigen, and 82% (2043) were seronegative in both assays. Figure 2 shows the prevalence of antibodies against HHV-8 lytic and latent antigens for HIV-infected and -uninfected mothers and children, by age group. For HHV-8, the prevalence of lytic antibodies was higher than that of latent antibodies at all ages, and the prevalence of both increased linearly with age (lytic, , and ; latent, , and ) or children (7% vs. 8%; P p P p .5 .5). The apparent differences seen in figure 2 for specific age groups were not statistically significant.
In children born to mothers with antibodies against HHV-8 lytic antigens, the prevalence of lytic antibodies decreased with age, from 21% (56/272) in children aged 0-3 months, to 12% (18/147) in those aged 4-6 months, and to 9% (7/ The relationship between maternal antibodies against HHV-8 lytic and latent antigens and presence of antibodies in children The prevalence of antibodies against lytic and latent HHV-8 antigens in children of HHV-8-infected mothers is shown in table 3, according to the HIV serostatus of mother and child. Compared with the situation in which both mother and child were HIV seronegative, maternal HIV infection alone was not associated with an increased risk of either lytic or latent HHV-8 antibodies being detected in the child. However, if the child was also HIV seropositive, the risk of the child having lytic (but not latent) HHV-8 antibodies was significantly increased (OR, 3.2; 95% CI, 1.7-6.1).
In total, 978 saliva samples were selected at random from mothers with children aged 11 year and were tested for evidence of HHV-8 DNA. Fifteen percent (145/978) of mothers had evidence of virus in saliva (mean virus load, 488,450 copies/mL; range, 1500-660,000 copies/mL). ). The prevalence of detectable HHV-8 DNA in saliva from .3 HIV-seronegative mothers was unrelated to the titer of antibodies against HHV-8 latent antigens but was related to those against lytic antigens (table 4). The prevalence of HHV-8 in saliva was 9% (34/375) in mothers who were seronegative for HHV-8 lytic antibodies, compared with 34% (42/122) in mothers with the highest titers of lytic antibodies (OR, 5.3; 95% CI, 3.2-8.8). Furthermore, the proportion of children with antibodies against HHV-8 lytic antigens was higher among HIVseronegative mothers with a high saliva HHV-8 load. Among children of mothers with no detectable HHV-8 in their saliva, 13% (70/528) had lytic HHV-8 antibodies, compared with 29% (8/28) of the children whose mothers had a saliva HHV-8 load of 150,000 copies/mL (OR, 2.6; 95% CI, 1.1-6.2; table 5).
A proportion of breast-milk samples were tested for evidence of HHV-8 DNA. The samples of breast milk were selected from among mothers who were found to have high titers of antibodies against lytic HHV-8 antigens. In total, 12 of 43 mothers had detectable levels of HHV-8 DNA in breast milk (mean virus load, 5800 copies/mL of breast milk; range, 1550-12,540 copies/mL).
DISCUSSION
The prevalence of antibodies against both lytic and latent HHV-8 antigens found in the present study and the linear increase in prevalence with increasing age are broadly comparable to the NOTE. Six hundred eleven mothers were analyzed for lytic antibody; 610 mothers were analyzed for latent antibody. Odds ratios (ORs) were adjusted for maternal age. CI, confidence interval. findings of other studies from Africa [8, 16, [22] [23] [24] [25] . We have confirmed, with considerably larger numbers of subjects than have been studied previously, the increased risk of a child being HHV-8 seropositive if the mother is, together with the increasing prevalence of anti-HHV-8 antibodies in children with increasing maternal antibody titers [10, 11, 26] . This result is suggestive of mother-to-child transmission of the virus. As with other studies from Africa and French Guyana, however, a proportion of children had HHV-8-seronegative mothers and so must have been infected from another source [10, 11, 26] . We did not recruit siblings or fathers of the children and so are unable to comment on these people as possible sources of HHV-8 infection. An increase in the prevalence of HHV-8 seropositivity among children of HHV-8-seropositive mothers was evident in these data only if the child (as well as the mother) was infected with HIV. HIV infection in the mother, but not the child, was not associated with a higher prevalence of antibodies against HHV-8 in the children. The exact mechanism by which HHV-8 is transmitted is unknown. Epidemiological evidence has pointed to sexual behaviors, such as deep kissing and oro-anal contact, among homosexual men [12, 13] . In Africa, however, where HHV-8 occurs in children, other routes of transmission are likely. HHV-8 DNA has been isolated from saliva samples of HHV-8-seropositive people, but shedding in saliva is intermittent [12, 13] . Here, we found that 15% of mothers had detectable HHV-8 in their saliva. Samples were obtained from the mothers only once, so this is likely to be an underestimate of the number of mothers who might carry HHV-8 virus in their saliva at some point in time. Nevertheless, HHV-8 in saliva was most prevalent in women with high titers of antibodies against HHV-8 lytic antigens (a risk factor for seropositivity in the child) and, at high copy numbers only, was also associated with a higher prevalence of antibodies in the child. These data therefore provide some evidence to support the view that transmission of HHV-8 from person to person might occur through saliva. HHV-8 DNA was also identified in a proportion of breast-milk samples, but at levels that were orders of magnitude below those found in saliva (and well below the levels in saliva that were associated with an increased prevalence of antibodies in the child). However, the volume of breast milk to which a child would be exposed is greater than that of saliva, so it must be considered a potential source of infection. We cannot rule out the possibility that a proportion of children were infected in utero or at birth, although previous research has shown this to be rare [25, 27] .
Our finding that a very high virus load in saliva is associated with transmission to the child raises the question of how the child is exposed to maternal saliva. An extensive questionnaire used during this study to collect information on living conditions did not find a clear-cut association with HHV-8 infection in the child (M.D., unpublished data). A recent review describes traditional medicinal practices involving the use of saliva that are common in Africa [28] . One example is the use of saliva to soothe itchy bites inflicted by particular insect vectors that could thus promote transmission of HHV-8 ("promoter arthropod" hypothesis) [29] .
Our observation that virus shedding in saliva is associated with high lytic, but not latent, antibody titers indicates that levels of antibodies against lytic (structural) antigens may be boosted by active viral replication. High lytic antibody titers may therefore serve as indicators of ongoing viral replication. Conversely, our observations could suggest that HHV-8 antibody levels in individuals who never reactivate and shed HHV-8 could be very low or undetectable. Here, 10% of mothers with undetectable antibodies against the lytic antigen K8.1 and 14% of mothers with undetectable antibodies against LANA had HHV-8 DNA identified in saliva by use of PCR.
The present study has limitations. The case-control design did not allow the incidence of HHV-8 to be determined among the children. In addition, a proportion of the children were !1 year of age and so were excluded from some of the final analyses, because their HHV-8 antibodies may have been maternal. However, our sample was drawn from mothers and children attending state-run vaccination clinics; vaccination coverage in KwaZulu/Natal is 190%, and vaccinations are free, so the study population would have been broadly representative of mothers and children in the area. We used both a lytic and a latent assay to measure HHV-8 infection. The correlation between these assays was poor. Both the lytic and latent assays have been used with African samples before [11, 24, 26, 30, 31] . The use of blood spots on filter paper in the present study may have resulted in a small loss of sensitivity. However, many of our results are in line with those from other studies, suggesting that, at a population level, these assays are performing well enough to examine risk factors for transmission of HHV-8.
